Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports.

نویسنده

  • Richard Elliott
چکیده

More than two years since Canada enacted the Jean Chrétien Pledge to Africa, no generic medication produced under compulsory license has yet been exported from Canada. In this feature article, Richard Elliott describes attempts by two Canadian generic pharmaceutical companies to navigate the complicated and unwieldy processes established under the Act, and, noting the government's pledge to review the law and fix it to make it work, prescribes a number of ways in which the process should be streamlined.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56.

In November 2003, Canada introduced legislation to amend the Patent Act so that manufacturers could obtain licences to make generic versions of patented pharmaceutical products for export to countries lacking sufficient capacity to produce their own. Bill C-56 aims to implement an August 2003 decision of the World Trade Organization (WTO) that relaxes its rules on pharmaceutical patents to allo...

متن کامل

Delivery past due: global precedent set under Canada's Access to Medicines Regime.

Four years to the month after Parliament passed a law to enable the supply of lower-cost generic medicines to developing countries in need, the first exports are finally about to happen. In this article, Richard Elliott provides an overview of recent developments under Canada's Access to Medicines Regime (CAMR), and identifies key reforms needed to streamline the regime so that it can more easi...

متن کامل

Canada's Access to Medicines Regime: Promise or Failure of Humanitarian Effort?

There is often a gap between promises made politically and the will to implement these promises meaningfully. One example is Canada's Access to Medicines Regime (CAMR). CAMR was enacted following a WTO decision that changed global intellectual property rules, allowing countries to issue compulsory licences for the production and export of domestically patented medicines to countries without pha...

متن کامل

A fair deal for the future: flexibilities under TRIPS.

When the Uruguay Rounds concluded in 1994, many countries signed on to the trade agreements creating the World Trade Organization (WTO) in hopes of benefiting from a system of trade rules “dedicated to open, fair and undistorted competition” (1). WTO members also undertook to implement the TradeRelated Aspects of Intellectual Property Rights (TRIPS) Agreement. Developing countries, major develo...

متن کامل

Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.

Canada was the first country to implement the WTO Decision of August 30, 2003, authorizing the export of generic drugs manufactured under a compulsory license to developing countries in response to a proposal brought forward by non-governmental organizations (NGOs) that now claim dissatisfaction with the Canadian legislation. This empirical case study examines what success means for an NGO camp...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • HIV/AIDS policy & law review

دوره 11 2-3  شماره 

صفحات  -

تاریخ انتشار 2006